Related Experiment Video

Updated: Mar 15, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K

Targeted Therapy for Hepatocellular Carcinoma

Nitin Ohri1, Andreas Kaubisch2, Madhur Garg1

  • 1Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.

Seminars in Radiation Oncology
|September 14, 2016
PubMed

Insights

Hepatocellular cancer (HCC) treatments are limited, necessitating new systemic options. This review explores emerging HCC drugs and radiotherapy combinations to improve patient outcomes.

Area of Science:

  • Hepatocellular carcinoma (HCC) research
  • Oncology drug development
  • Cancer therapy combinations

Background:

  • Hepatocellular cancer (HCC) is a major global cause of cancer mortality.
  • Most HCC patients are not candidates for curative local treatments.
  • Current systemic therapy (sorafenib) offers limited survival benefits for advanced HCC.

Purpose of the Study:

  • To review and categorize novel systemic drugs and targets for HCC treatment.
  • To explore the potential of combining new HCC agents with radiotherapy.
  • To guide future research for improved HCC patient outcomes.

Main Methods:

  • Literature review of drugs and targets in various phases of HCC testing.
  • Analysis of potential combination therapies with radiotherapy.
  • Identification of promising research directions.

Main Results:

  • Identification of multiple novel systemic agents and molecular targets for HCC.
  • Evaluation of synergistic potential between targeted therapies and radiotherapy.
  • Categorization of therapeutic strategies based on development phase.

Conclusions:

  • Novel systemic agents and combination therapies show promise for HCC.
  • Radiotherapy integration may enhance the efficacy of targeted HCC treatments.
  • Further research is essential to translate these findings into clinical practice.

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K